Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Bupropion
(Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)		[2] Bupropion; Bupropion Hydrochloride[1] Bupropion 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[5] 8, 18, 21, 96, 171 💬
2 Naltrexone [2] NALTREXONE; NALTREXONE HYDROCHLORIDE[1] Naltrexone 💬[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[13] 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
3 Triamcinolone
(Naltrexone)		[4] Kenalog; Naltrexone; Triamcinolone; Triamcinolone Acetonide[1] Triamcinolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[11] 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬